Close Menu
Home › SpeeDx, UgenTec Collaborate on Interpretation for Infectious Disease Dx Results

SpeeDx, UgenTec Collaborate on Interpretation for Infectious Disease Dx Results

Jan 16, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx has announced that Belgian software maker UgenTec will provide interpretation for results generated by the firm's infectious disease diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Qiagen Says It Is Fielding Acquisition Offers

  2. Cancer Diagnostics Firm Lucence Raises $20M

  3. Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

  4. Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear

    Premium

  5. T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.